Translational Development Acquisition Corp.
TDACU- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0001926599
No open-market purchases or sales by Translational Development Acquisition Corp. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $365.9K in total; no superinvestor holds it.
Holders of 5% or more of TDACU
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Translational Development Acquisition Corp., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Magnetar Financial LLC | 13G | 7.53%1.30M shares | New | Jan 29, 20251 filing | Jan 29, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Translational Development Acquisition Corp., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jan 29, 202510:07 AM ET | Magnetar Financial LLCand 3 others | 13G | 7.53%1.30M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Translational Development Acquisition Corp. shares.
No Form 144 notices for Translational Development Acquisition Corp. are on file.